April 18th, 2025
Coronavirus Updates - Page 7
Tesla Set to Build RNA Microfactories for Coronavirus Vaccine
By Tolu Ajiboye
July 6th, 2020
Tesla and CureVac are currently working together to build portable RNA printers which would help in the creation of a coronavirus vaccine.
GlaxoSmithKline and Sanofi to Supply UK Government with 60M COVID-19 Vaccine Doses
By Darya Rudz
July 6th, 2020
Following the news, both Sanofi and GlaxoSmithKline stocks jumped. The latest closing price for Sanofi was $51.62. GlaxoSmithKline shares ended at $41.22 at the latest session.
Pfizer (PFE), BioNTech (BNTX) Stocks Posititively Reacted to Coronavirus Vaccine Trial
By Darya Rudz
July 2nd, 2020
Following the positive news, Pfizer and BioNTech shares managed to jump 5% and 2.2% accordingly on Wednesday. PFE closed with a 3% rise while BTNX lost 4%.
Gold Price Peaks Above $1800 for the First Time Since 2011
By Godfrey Benjamin
July 1st, 2020
Gold is currently experiencing a new price high since 2011. This increase is fueled on grounds of possible measures to help curtail the new rising cases COVID-19.
U.S. Stocks End Q2 2020 as Best Quarter Since 1998, Coronavirus Concerns Still Hover Around
By Bhushan Akolkar
July 1st, 2020
While in Q2 2020 the stock markets have managed to rebound considerably well after a major correction in Q1 2020, the Fed Chairman and Treasury Secretary warned that failing to control the rising COVID-19 cases can put major pressure on the U.S. economy.
AZN Stock Up 0.6%, WHO Marks AstraZeneca and Moderna as Leaders in Race for COVID-19 Vaccine
By Chuks Chukwuka
June 29th, 2020
The World Health Organization highlighted the progress of AstraZeneca seeking for the COVID-19 vaccine. UK-based company has moved to the human trial stage. Moderna is not far behind.
Why Vaxart, Inovio Pharmaceuticals, and Sorrento Therapeutics Stocks Took Off on Thursday
By Darya Rudz
June 26th, 2020
The number of COVID-19 cases is rising again, and the companies working on the vaccine will likely further benefit from a cash flow into them. Vaxart, Inovio Pharmaceuticals, and Sorrento Therapeutics stocks are good examples of this advantage.
INO Stock Jumps 15% as Inovio Secures Government Funding for COVID-19 Vaccine Device
By Godfrey Benjamin
June 25th, 2020
Inovio has secured funding from the U.S Department of Defense to expedite the development and production of its Cellectra 3PSP Smart Devices for the administration of the COVID-19 vaccine. INO stock is up.
AZN Stock Up 1.46% as AstraZeneca’s COVID-19 Vaccine Animal Trials Give Promising Results
By Godfrey Benjamin
June 24th, 2020
AstraZeneca’s COVID-19 vaccine clinical trials gave possible results. Hopes to see the speedy release of the vaccine boost AZN stock.
European Stocks Fall as Confirmed Coronavirus Cases Begin to Rise Again
By Tolu Ajiboye
June 22nd, 2020
As coronavirus cases all over the world began to rise again, European stocks are feeling the heat and have started to fall, with many of them being afraid of increased lockdown.
Better Buy: Moderna (MRNA) vs Gilead Sciences (GILD)
By Tolu Ajiboye
June 18th, 2020
The coronavirus pandemic is raging and there’s still no treatment or vaccine. Regardless, let’s look at the stocks of two major biotech companies: Gilead Sciences and Moderna.
Austrian Government Grants Ardor Blockchain-Powered Project Share of $26M COVID-19 Tech Fund
By Kseniia Klichova
June 18th, 2020
The Austrian government has allocated $26 million to support COVID-fighting startups, with one blockchain-related venture in line for a share of the funds.
CureVac Set to Begin Human Trials of Coronavirus Vaccine in Germany
By Muhaimin Olowoporoku
June 17th, 2020
CureVac is joining the row of biotech companies that are ready to test their coronavirus vaccine candidates on patients.
Dow Up 500 Points after Positive News on Potential Coronavirus Treatment Dexamethasone
By Bhushan Akolkar
June 17th, 2020
In a major breakthrough, researchers from England have discovered that Dexamethasone can help to reduce deaths by one-third for COVID-19 patients under critical conditions. Markets reacted positively to the news.
Germany to Buy 23% Stake for 300M Euros in CureVac as World Races for COVID-19 Vaccine
By Godfrey Benjamin
June 16th, 2020
In a bid to fight off foreign interference, Germany is set to invest in CureVac, a biopharmaceutical firm that is working on the development of a coronavirus vaccine. The deal is worth 300 million Euros